PR Newswire
Bridge Biotherapeutics to Present at the 2022 BIO International Convention
May 26, 2022
SEONGNAM, South Korea, May 26, 2022 /PRNewswire/ -- Bridge Biotherapeutics Inc. (KQ288330), a South Korean clinical-stage biotechnology company focused on developing novel drugs for cancer, fibrosis and inflammation, is scheduled to give a company presentation on Thursday, June 16 at the 2022 BIO International Convention taking place in San Diego, California, between June 13 - 16, 2022. Pavel Printsev, Director of Business Development, will provide an overview of the company as well as an intr